15 results
6-K
EX-10.1
CLYYF
Celyad Oncology SA
7 Jan 21
Celyad Oncology Announces Equity Purchase Agreement for up to $40 Million with Lincoln Park Capital
7:29am
) of the ADSs or Common Shares or (ii) hedging transaction, which establishes a net short position with respect to the ADSs or Common Shares, and will not engage … in such short sales or hedging transactions involving the ADSs or the Common Shares during the term of this Agreement.
4. REPRESENTATIONS
6-K
EX-99.1
CLYYF
Celyad Oncology SA
7 Jan 21
Celyad Oncology Announces Equity Purchase Agreement for up to $40 Million with Lincoln Park Capital
7:29am
or indirect short selling or hedging of Celyad Oncology’s shares of common stock. The Purchase Agreement may be terminated by Celyad Oncology at any time
424B5
CLYYF
Celyad Oncology SA
7 Jan 21
Prospectus supplement for primary offering
7:28am
or hedging activity and shall not engage in any activity of such kind at any time hereafter.
As consideration for LPC’s commitments under the Purchase … or indirectly, any short sale (as such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of our ADSs or any hedging transaction
424B5
v6c8gf asgw476
11 Sep 20
Prospectus supplement for primary offering
5:13pm
F-3
glq3 afeayays
28 Aug 20
Shelf registration (foreign)
4:02pm
424B5
59a4qh8f mmwmvjvn
10 Sep 19
Prospectus supplement for primary offering
4:09pm
424B5
4ho11r2brmovfwu yo1
18 May 18
Prospectus supplement for primary offering
5:02pm
424B5
j2gptv95zgzq
16 May 18
Prospectus supplement for primary offering
12:00am
20-F
m2dmfjxdy
8 Apr 16
Annual report (foreign)
12:00am
- Prev
- 1
- Next